Evolv Technology develops artificial intelligence (AI)-powered weapons-screening systems used at venues, schools, hospitals, and public spaces. Its earnings releases are closely watched because the company is in the middle of a strategic transition toward recurring, subscription-based revenue, away from one-time product sales through legacy distribution partners. This quarter matters because it will show whether ARR growth and margin improvement are staying on track after several quarters of strong top-line expansion. A year ago, the third quarter included roughly $7.5 million in non-recurring items, so comparability is unusually complex. Investors are watching whether underlying momentum, customer additions, and the shift to purchase-based subscriptions can sustain growth and push the company toward its profitability targets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter of 2026, analysts expect Evolv to report a net loss of $0.06 per share on revenue of approximately $45.61 million, according to consensus estimates tracked by MarketBeat and Zacks. That revenue figure would represent growth of roughly 6% from the $42.85 million reported in the third quarter of 2025. The modest growth rate reflects a difficult comparison: last year's quarter was boosted by the largest customer order in the company's history, intellectual property (IP) license fees tied to its phasing-out distribution model, and short-term rental agreements that concluded in the period. On the profitability side, consensus implies a wider per-share loss than the $0.01 GAAP loss (and $0.02 adjusted loss) reported a year earlier.
Beyond the headline numbers, investors will be watching ARR, which reached $132.7 million (up 20% year over year) at the end of the second quarter of 2026, as well as net revenue retention and adjusted EBITDA margin, which stood at 10.1% in the prior quarter. Management's full-year 2026 outlook for revenue of $180 million–$185 million and adjusted EBITDA of $15 million–$16 million will also be tested against third-quarter results and any updated commentary. From what I see, these metrics provide a clearer picture of the underlying business than the reported revenue alone.
Sentiment heading into the third-quarter report has been mixed. Evolv's shares have traded well below their 12-month high of $7.51, recently hovering near $4.60, even as the average analyst price target sits near $9.81 with a "Moderate Buy" consensus rating. The stock's last earnings release illustrated the market's sensitivity to execution: the company beat revenue expectations in the second quarter but posted a wider loss per share than expected, prompting scrutiny of profitability even as management raised its full-year revenue guidance. Heading into this print, the key risks include the difficult year-over-year comparison, the potential for margin pressure from Gen2 hardware upgrades and supply-chain constraints, and the broader market's tolerance for continued net losses at a growth-oriented, higher-beta security technology company.
Following the third-quarter report, investors should focus on several forward-looking signals. First, the trajectory of ARR relative to total revenue will be important: management has signaled that ARR growth should outpace revenue growth as the legacy distribution model is fully wound down, making ARR a cleaner read on underlying demand than reported revenue alone.
Second, watch net revenue retention and customer-addition trends. Evolv added more than 70 new customers in the second quarter of 2026, and sustained expansion within existing deployments—often through Gen2 Express upgrades that reset subscriptions with fresh multi-year commitments—supports the durability of the revenue base.
Third, monitor adjusted EBITDA margin progression and any commentary on the path toward the company's longer-term target of over $500 million in revenue by 2031 with 25%-plus EBITDA margins. Near-term margin pressure from the product mix shift and supply-chain constraints could temper investor enthusiasm even if revenue lands in line.
Finally, keep an eye on remaining performance obligations (RPO), which reflect contracted but not yet recognized revenue and provide visibility into future top-line growth. Any revision to full-year guidance on the earnings call will likely drive the immediate stock reaction more than the reported figures themselves. I’m watching this closely for any updates on these fronts.
In preparing for earnings like these, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get a sense of momentum and how the stock has been behaving relative to broader market signals. It helps me cross-check technical patterns without spending hours on manual analysis, especially when tracking names transitioning to subscription models. The tool has been a useful part of my routine for spotting potential entry or exit points based on AI-driven indicators.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for EVLV moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 28 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EVLV as a result. In 55 of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for EVLV just turned positive on October 21, 2026. Looking at past instances where EVLV's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
EVLV moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVLV advanced for three days, in 207 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
EVLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where EVLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for EVLV entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EVLV's P/B Ratio (6.949) is slightly higher than the industry average of (2.996). EVLV's P/E Ratio (-228.000) is considerably lower than the industry average of (3.471). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.749). Dividend Yield (0.000) settles around the average of (0.244) among similar stocks. EVLV's P/S Ratio (5.189) is slightly higher than the industry average of (2.085).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. EVLV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributor of products to consumers through TV, telephone, online and mobile
Industry MiscellaneousCommercialServices